According to the Parkinson Foundation, almost one million people are living with Parkinson disease in the US which is expected to rise to 1.2 million in 2030.
The global cyclosporine market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Cyclosporine works by suppressing the immune system’s responses further preventing the immune system from attacking healthy tissues.